文献速递免疫规划

成人乙型肝炎免疫接种后自身免疫性疾病:文献综述与Meta分析

Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
PubMed 文献 · Vaccine · 2018-08-09

该研究检索1990年1月至2017年3月同行评议文献,评估成人乙型肝炎疫苗接种与自身免疫性疾病发生的因果关系,纳入19篇报告21项结果的文献,其中14项结果进入Meta分析。总体未观察到乙型肝炎疫苗接种与自身免疫性疾病发病存在关联,合并比值比为1.06(95%CI 0.93-1.21),异质性无统计学意义。尽管有个案报告,但无可靠科学证据表明乙型肝炎疫苗接种会导致自身免疫性疾病。

要点

  • 成人乙型肝炎疫苗接种与自身免疫性疾病发病总体无关联,合并OR为1.06(95%CI 0.93-1.21)。
  • 仅一项研究显示乙型肝炎免疫接种与自身免疫性疾病之间存在显著超额风险。
  • 尽管有多例个案报告,但无可靠科学证据表明乙型肝炎疫苗接种会导致自身免疫性疾病。

核心结论

  • 总体未观察到乙型肝炎疫苗接种与自身免疫性疾病发病之间的关联,合并比值比为1.06(95%CI 0.93-1.21),异质性无统计学意义。
  • 尽管有多例个案报告,但无可靠科学证据表明乙型肝炎疫苗接种会导致自身免疫性疾病。

研究设计与样本

  • 研究为文献综述与Meta分析,检索1990年1月至2017年3月的同行评议文献,纳入报告成人乙型肝炎疫苗接种后自身免疫性疾病发病率的对照研究。
  • 从1297项研究中进一步评估259项,最终综述49篇,其中19篇相关论文报告21项结果,14项结果纳入Meta分析。

主要发现

  • 总体未观察到乙型肝炎疫苗接种与自身免疫性疾病发病之间的关联,合并比值比为1.06(95%CI 0.93-1.21),异质性无统计学意义。
  • 仅一项研究显示乙型肝炎免疫接种与自身免疫性疾病之间存在显著超额风险。

关键数值与推荐

  • 合并比值比为1.06(95%CI 0.93-1.21),异质性无统计学意义。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To assess if hepatitis B vaccination in adults is causally associated with autoimmune diseases. Such causation has been claimed based mainly on case reports and uncontrolled studies, and a syndrome 'Autoimmune/autoinflammatory Disorder Induced by Adjuvants' (ASIA) has been claimed to be linked to immunization, particularly hepatitis B vaccination. METHODS: Review of peer-reviewed literature from January 1990 to March 2017 identifying controlled studies with documented incidence of autoimmune diseases occurring after hepatitis B vaccinations in adults. From 1297 studies identified, 259 were further assessed and 49 reviewed further; 19 relevant papers reporting 21 results are reviewed here, and 14 results included in a meta-analysis. RESULTS: Overall no association between hepatitis B vaccination and the onset of autoimmune diseases was seen. The overall odds ratio was 1.06, with 95% confidence limits of 0.93-1.21, with non-significant heterogeneity. Only one study showed a significant excess risk between hepatitis B immunisation and autoimmune disease. CONCLUSIONS: Despite multiple case reports, there is no reliable scientific evidence of autoimmune diseases being caused by hepatitis B vaccinations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Elwood JM, Ameratunga R. Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA). Vaccine. 2018. PMID: 30100071. doi:10.1016/j.vaccine.2018.07.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。